Clinical trial
Combination Chemotherapy in Treating Patients With Untreated Ovarian…
NCT00003385 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003385 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer |
| Official title | A Phase I Study of Paclitaxel, Carboplatin, and Increasing Doses of Doxil in Untreated Ovarian, Peritoneal, and Tubal Carcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel, pegylated liposomal doxorubicin hydrochloride |
| Enrollment | 48 |
| Start date | Mar 1, 1999 |
| Primary completion | Jan 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | May 27, 2013 |
| Countries | Norway, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: